U.S. health regulators approve J&J, Pharmacyclics lymphoma drug

(Reuters) - U.S. health regulators on Wednesday approved a drug to treat a rare and aggressive form of non-Hodgkin lymphoma developed by Johnson & Johnson and Pharmacyclics Inc, marking the second drug that received the FDA's new breakthrough therapy designation to gain approval.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news